If you're one of the insider "us," all is good, and

New Post Public Reply Private Reply Replies (3) Message Board
plutonium WinnerTakeAll #6339
475
If you're one of the insider "us," all is good, and anything goes. All the rest are "them," and subject to belittling, name-calling, and minimizing.

I for one am glad that you understand that. Actually there are three groups:

1. the share price is everything, it is the only thing crowd, the group showing the most growth

2. the Berman derangement syndrome group, some of whom are also in the share price group, the group that believes the CEO is the root of all evil in the world

3. the group that understands that companies do not become blue chip stocks overnight and looks for company progress, maturity and growth. Unfortunately this group is currently being overwhelmed by the "iHub" sentiment and the group grows smaller by the day. Worse there are people who lurk in this group because it is a good place to start a conspiracy theory or two, so this group may actually be smaller then people may think


This message board used to be a haven, then it went quiet for the most part, but when nonseq became a share price is everything, the only thing guy, this board has become a microcosm of the iHub board and the only real discussion, and it pains me to say this, occurs on the Yahoo board. Sad but true.

This board used to have a code. The code went like this ... no personal attacks, if you had bad things to say, don't say it, go somewhere else. No more. I am retired and have a lot of time, but I venture to say that my PM gets more work from people that used to post on this message board then the board does itself these days. And I am not the cause of it. I am a symptom of it. And that is bad and makes the board look unmanageable, like iHub.

Finally, one last thing. For the most part people who trade stocks know very little or anything at all about how companies actually operate. Many posters don't care to learn and would rather play the rumor and innuendo games. But there are some who previously did not understand, and for example never read a quarterly or annual report in their lives. A few have seen the light. For example I know a broker who posts on this board and it pains me to say that this fellow never read a quarterly report and was ready to engage in rumor and innuendo and now he does read reports and understands the pressures small companies operate under and also understands that in business some things work out and some things do not. Unfortunately this poster now only posts on the Yahoo board when it comes to DECN.

Cults on a message board.... LOLOL.
3

Decision Diagnostics Corp (DECN) Stock Research Links

DECN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

SmartFinancial Announces Earnings Release and Call Schedule

Updated Category News Views 143

SmartFinancial Announces Upcoming Earnings Release SmartFinancial, Inc. (NYSE: SMBK) has revealed important details regarding its Fourth Quarter earnings for the year 2024. This is an exciting time for investors and stakeholders as the company prepares to share insights into its financial performance. Earnings Release Date and Conference Call Information The earnings...

Continue Reading
IntouchCX Enhances Trust and Safety with WebPurify Acquisition

Updated Category News Views 302

IntouchCX Strengthens Trust and Safety Solutions Through Acquisition IntouchCX has recently made headlines with its acquisition of WebPurify, a leading provider of innovative content moderation solutions that harness the power of artificial intelligence. This strategic move represents a significant advancement in IntouchCX's mission to redefine Trust and Safety solutions,...

Continue Reading
Y-mAbs Therapeutics to Present at Key Investor Conferences

Updated Category News Views 66

Y-mAbs Therapeutics Engages Investors at Upcoming Conferences This September, Y-mAbs Therapeutics, Inc. (Nasdaq: YMAB), a key player in the biopharmaceutical industry, is poised to attract investor interest. The company is known for its innovative radioimmunotherapy and antibody-based treatments designed to transform cancer care. Michael Rossi, the energetic CEO of...

Continue Reading
CorVel Corporation Reports Strong Financial Growth

Updated Category News Views 138

Overview of CorVel's Financial Performance CorVel Corporation (NASDAQ: CRVL) recently unveiled impressive results for the quarter and fiscal year, showcasing strong revenue gains and enhanced earnings metrics. The quarterly revenue hit $232 million, a notable rise from $207 million compared to the same quarter last year. This upward trend is mirrored across the fiscal...

Continue Reading
IQAX Achieves Interoperability Approval for eBL Solutions

Updated Category News Views 178

IQAX eBL Interoperability Approval Highlights IQAX Limited has made significant strides in enhancing its electronic bill of lading (eBL) solution by receiving official approval from the International Group of P&I Clubs (IG P&I Clubs). This approval affirms the capabilities of IQAX eBL's interoperable addendum, empowering users to perform eBL transactions across different...

Continue Reading